It is well known that chemerin is associated with BMI [5], hyperinsulinemia [51], insulin resistance [52, 53] and dyslipidaemia [54] in diseases associated with development of the metabolic syndrome, such as T2D. Here, RARRES2 is linked to Insulin resistance.